Evidence-based Strategies for the Management of Central Venous Catheters

Central venous catheters (CVCs) are an important component of cancer treatment and require multidisciplinary care due to significant complications associated with vascular access devices. Several organizations have developed evidence-based strategies to promote a decrease in CVC-associated complications including mechanical injury, thrombosis and infections. It is important that oncology clinicians including nurses are up-to-date with all evidence-based training related to CVC line placement and maintenance to minimize or eliminate complications associated with CVCs and enhance patient outcomes during treatment.

Target Audience

This educational program is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:    

  • Identify different types of central venous catheters or vascular access devices used in oncology care and outline their associated functions
  • Discuss evidence-based strategies for the care and maintenance of vascular access devices
  • Outline evidence-based strategies to address complications associated with central venous catheters using insertion and maintenance bundles
Additional information
Supporters: 

This activity is supported by an educational grant from:

  • AstraZeneca
  • Genentech
  • Pfizer
  • Taiho Oncology, Inc.

This activity is supported by an independent educational grant from Merck & Co., Inc.

Course summary
Available credit: 
  • 0.71 ANCC contact hours
  • 0.71 Participation
Course opens: 
05/15/2019
Course expires: 
05/15/2020
Cost:
$0.00
Part of: 
Recorded Presentations from the NCCN 2019 Nursing Program: Advancing Oncology Nursing™

MiKaela Olsen, APRN-CNS, MS, AOCNS, FAAN
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

 

NCCN Medical Education Disclosure Policy

It is the policy of NCCN that every 12 months, all faculty, moderators, activity planners and all internal planning staff participating in NCCN continuing education activities are expected to disclose any financial relationships with a commercial interest as defined by the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. In addition, all faculty presentations have been reviewed for adherence to the ACCME’s Standards for Commercial Support (the provider develops activities/educational interventions independent of commercial interests [SCS 1, 2 and 6] by experts on the topics).

Per the ACCME Standards for Commercial Support, individuals who do not disclose relevant financial relationships will be disqualified from involvement in the CE activity as a content developer, planner, or presenter. A complete list of individuals’ relationships with external entities is available upon request.

Definitions 

NCCN continuing education considers financial relationships to create a “conflict of interest” when an individual has both a financial relationship with a commercial interest and the opportunity to affect CE content about the products or services of a commercial interest with which he/she and/or a spouse or partner has a financial relationship.

NCCN continuing education considers “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. NCCN does not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship.

Faculty Disclaimers 

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling.

Faculty Disclosures

The faculty listed below discloses no relevant financial relationships:

MiKaela Olsen, APRN-CNS, MS, AOCNS, FAAN

NCCN Staff Disclosures

The NCCN Activity Planning staff listed below discloses no relevant financial relationships:

Robert W. Carlson, MD; Melissa Esplen; Mark A. Geisler; Kristina M. Gregory, RN, MSN, OCN; Kristin Kline Hasson; Rose Joyce; Karen Kanefield; Lisa G. Kimbro, MBA, CPA (Employed by NCCN until 8/10/18); Wui-Jin Koh, MD; Joan S. McClure, MS (Employed by NCCN until 8/1/18); Lisa Perfidio, MS; Sarah Sinclair; Kathy Ann Smith, CHCP; Gary J. Weyhmuller, MBA, SPHR

The NCCN Clinical staff listed below discloses no relevant financial relationships:

Ndiya Ogba, PhD

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

NCCN designates this educational activity for a maximum of  0.71 contact hours.

Available Credit

  • 0.71 ANCC contact hours
  • 0.71 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need: